Industry welcomes Brexit proposal and possible UK-EMA cooperation

Europe’s leading pharma trade body, the European Federation of Pharmaceutical Industries and Associations (EFPIA), has endorsed the Brexit transitional deal proposed by the UK and European Union.

In a statement, EFPIA director general Nathalie Moll said: “From our sector’s perspective the deal on the table is infinitely better than the UK leaving the European Union with no deal in place.”

The group particularly welcomed new language in the proposed deal which recognizes “the possibility of cooperation of United Kingdom authorities with Union agencies such as the European Medicines Agency (EMA).”